TScan Therapeutics Announces Updates to its Board of Directors
Go back to TScan Therapeutics Announces Updates to its Board of Directors| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.39 +0.02 (5.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.37 | 52 Week High | $26.80 | |||
| Open | $0.37 | 52 Week Low | $23.00 | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $0.00 | |||
| Volume | 1,674,544 | |||||
